S kin develops in the fetus when dermal fibroblasts establish a porous, 'basket-weave' scaffold, providing the tensile strength and extensibility needed for the structural integrity and for protective and sensing functions. Injuries to the skin commonly lead to loss of these frameworks and replacement by scar tissues, which have greatly limited functions. Scar tissue is rarely observed in lower vertebrates, where the normal response to injury is a complete regeneration of the original dermal structure. However, mammals have evolved to heal with scar tissue and undergo a regeneration-to-scar phenotypic transition during fetal life 1,2 . This transition has been documented in the back-skin of all mammalian embryos studied to date including humans [3][4][5][6] [7] . Previous studies into the fetal commencement of scarring have focused on a multitude of environmental differences between early and late fetal stages, including inflammatory responses to injury, expressions of morphogenetic proteins, growth factors and extracellular matrix (ECM) components such as hyaluronic acid 8 . In the early 1990s, the influence of the environment on the commencement of scarring was addressed by performing fetal/adult heterochronic transplantations of back-skin tissues in sheep 9 . The study found that donor back-skin tissues respond to injury (scar/regenerate) independent of the host microenvironment or the developmental stage. Thus, the authors concluded that the determining factor (or factors) of the commencement of scarring is probably intrinsic to the transplanted back-skin graft, most likely its fibroblasts, the tissue's primary secretors of the ECM 9, 10 . More recently, we have discovered that functionally diverse lineages of fibroblasts coexist in the mouse back-skin and oral cavity 11 . Embryonic cells that have expressed engrailed 1 (En1), termed En1-lineage-past fibroblasts (EPFs), are the primary contributors to scarring in various models of pathological scars. Conversely, En1-lineage-naive fibroblasts (ENFs) do not participate in scar production. By transplanting adult ENFs or EPFs in different anatomical locations, we determined that the difference in the capacity of EPFs and ENFs to form a scar in vivo is cell intrinsic and permanent 11 . Here, we followed the fates of EPF and ENF progenitors. We used genetic fate-mapping approaches at single-cell and lineage levels, live three-dimensional (3D) confocal imaging of lineage-specific cellular migrations and immunolabelling coupled with in silico approaches to determine how the dermal structure in the back-skin develops. We find that ENFs form the sculptures of the dermal lattice and that their cell lineage declines during development, concurrent with a surge in EPF numbers that predisposes back-skin to scarring.
S kin develops in the fetus when dermal fibroblasts establish a porous, 'basket-weave' scaffold, providing the tensile strength and extensibility needed for the structural integrity and for protective and sensing functions. Injuries to the skin commonly lead to loss of these frameworks and replacement by scar tissues, which have greatly limited functions. Scar tissue is rarely observed in lower vertebrates, where the normal response to injury is a complete regeneration of the original dermal structure. However, mammals have evolved to heal with scar tissue and undergo a regeneration-to-scar phenotypic transition during fetal life 1, 2 . This transition has been documented in the back-skin of all mammalian embryos studied to date including humans [3] [4] [5] [6] [7] . Previous studies into the fetal commencement of scarring have focused on a multitude of environmental differences between early and late fetal stages, including inflammatory responses to injury, expressions of morphogenetic proteins, growth factors and extracellular matrix (ECM) components such as hyaluronic acid 8 . In the early 1990s, the influence of the environment on the commencement of scarring was addressed by performing fetal/adult heterochronic transplantations of back-skin tissues in sheep 9 . The study found that donor back-skin tissues respond to injury (scar/regenerate) independent of the host microenvironment or the developmental stage. Thus, the authors concluded that the determining factor (or factors) of the commencement of scarring is probably intrinsic to the transplanted back-skin graft, most likely its fibroblasts, the tissue's primary secretors of the ECM 9, 10 . More recently, we have discovered that functionally diverse lineages of fibroblasts coexist in the mouse back-skin and oral cavity 11 . Embryonic cells that have expressed engrailed 1 (En1), termed En1-lineage-past fibroblasts (EPFs), are the primary contributors to scarring in various models of pathological scars. Conversely, En1-lineage-naive fibroblasts (ENFs) do not participate in scar production. By transplanting adult ENFs or EPFs in different anatomical locations, we determined that the difference in the capacity of EPFs and ENFs to form a scar in vivo is cell intrinsic and permanent 11 . Here, we followed the fates of EPF and ENF progenitors. We used genetic fate-mapping approaches at single-cell and lineage levels, live three-dimensional (3D) confocal imaging of lineage-specific cellular migrations and immunolabelling coupled with in silico approaches to determine how the dermal structure in the back-skin develops. We find that ENFs form the sculptures of the dermal lattice and that their cell lineage declines during development, concurrent with a surge in EPF numbers that predisposes back-skin to scarring.
Results

ENFs are replaced by EPFs during back-skin development. The
En1 gene is expressed in a small subset of early embryonic cells and switched off permanently later in embryogenesis 11 . To distinguish En1-expressing cells and to follow their fibroblastic descendants in the developing back-skin, we used a transgenic mouse system where En1 expression drives genetic rearrangements (En1 Cre
Cre with a reporter mouse system (R26 mTmG ), generated offspring where the genetic rearrangement replaced membrane-bound tomato red protein (RFP) expression with membrane-bound green fluorescence protein (GFP) expression 12 ( Fig. 1a) . The permanent replacement of RFP with GFP in all descendant cells allowed purification schemes of EPFs and ENFs based on GFP , Ania Stefanska 1 back-skin. Dermal fibroblasts were mostly ENFs early on and their numbers declined slowly during subsequent development, followed by a steep decline between embryonic day 14.5 (E14.5) and E18.5 (~90% down to ~20%; Fig. 1b,c) . The drop in ENF numbers was proportional to total dermal cells (including haematopoietic, endothelial and lymphatic) and to dermal fibroblasts alone (Lin − ), indicating a clonal disadvantage to ENFs compared to all other dermal progenitors. Conversely, EPF numbers increased from ~2% of dermal cells at E14.5 (EPF/ENF ratio = 1/33) to ~72% at postnatal day 0 (P0) (EPF/ENF ratio = 4/1) (Fig. 1b,c) and in proportion to all other dermal progenitors (Fig. 1c) . We then placed ENF and EPF lineages in relation to previously described adult mesenchymal cell populations based on the expression of surface markers ( Supplementary Fig. 1 ). About 3% of Lin − cells expressed fibro/adipogenic progenitor (FAP) markers [13] [14] [15] (Lin (see Methods) neonate sections showed that adipocytes (fatty acidbinding protein 4 (FABP4)) or preadipocytes 18 (proten delta homologue 1 (Dlk1) and stem cells antigen 1 (Sca1)) were more abundant in EPFs ( Supplementary Fig. 2a-c) . Similarly, the smooth muscle marker α -smooth muscle actin (α -SMA) was enriched in EPFs compared to ENFs ( Supplementary Fig. 2d ). Immunostaining of reticular and papillary dermis markers (Dlk1, tenascin-C (TNC) and CD26) showed that their expression was not exclusive to either lineage ( Supplementary Fig. 2b ,e,f), indicating that EPFs and ENFs do not preferentially allocate to either anatomical location.
To determine whether the decline in ENF numbers is due to programmed cell death or a decrease in proliferation, we performed TdT-mediated dUTP nick end labelling (TUNEL) staining and immunolabelling of cleaved caspase 3 (Cas3) and the proliferation marker Ki67 on sections of E14.5, E16.5 and E18.5 En1 Cre ;R26 mTmG embryos. ENFs underwent significantly more apoptosis than EPFs at E14.5 and E16.5 (Fig. 1e,f) . Conversely, the number of proliferating EPFs steadily increased from E14.5 to E18.5, whereas ENF proliferation significantly decreased (Fig. 1d,f) . Together, our results show that the decay in the ENF population is primarily due to a clonal disadvantage.
To study the clonal dynamics of ENF-to-EPF replacements in situ at single-cell levels, we used a transgenic 'Rainbow' reporter system (En1 Cre ;R26 VT2/GK3 ) 19 . From the moment of En1 expression, individual EPF progenitors were genetically marked with one out of three alternate fluorescent colours (yellow fluorescent protein (YFP), RFP or cyan fluorescent protein (CFP)), whereas ENFs expressed GFP. EPF progenitors were absent in the dermis at E9.5 and first appeared at E10.5 ( Fig. 2a-d) . Coronal sections at E10.5 showed that single EPFs and monoclones developed in close association with the ectoderm and then extend from the most anterior regions (neck level) down to half of the trunk (Fig. 2b,c) . EPFs remained absent in most posterior regions (including hindlimbs) at this stage. At E11.5, EPFs formed two parallel mid-lateral lines that covered the entire back (Fig. 2e) . 3D reconstruction of E12.5 embryos showed that EPFs arrange themselves in an arc across the back-skin, with migration 'protrusions' at anterior sites ( Fig. 2f Cre ;R26 mTmG embryos; arrows indicate Ki67-positive or Cas3-positive cells, respectively. Scale bars, 50 µ m. f, EPFs and ENFs positive for Ki67, Cas3 or TUNEL. n = optical fields analysed from sections of three E14.5 embryos, two E16.5 embryos and one E18.5 embryo stained for Ki67 (n = 24, 28 and 16, respectively), Cas3 (n = 20, 15 and 14, respectively) and TUNEL (n = 9, 28 and 7, respectively). Mean ± s.e.m. ANOVA, Tukey test, *P < 0.05, **P < 0.01, ***P < 0.001. Additional adjusted P values are listed in Supplementary Table 1 .
Unexpectedly, we found that ENFs deposited fibronectin fibres, but not collagen I and collagen III (Fig. 2g) , indicating that ENFs generate a provisional matrix. At anterior sites, collagen I and collagen III fibres were visible within the dermal matrix in association with EPF clones, indicating that EPFs form a 'mature' dermis (Fig. 2h,i) . Indeed, at later stages, collagen I expression was associated with EPFs ( Supplementary Fig 3) . To view the dynamics of ENF-to-EPF replacement, we performed live 3D confocal imaging of the developing back-skin of En1 Cre ;R26 mTmG embryos (E12.5) at the anterior margin of the EPF arc ( Supplementary Fig. 4 ). We found that the ENF cytological structure is displaced to create open gaps into which EPFs migrated (Fig. 2j, Supplementary Fig. 4 and Supplementary Video 2). EPFs colonized the provisional dermis, through both dorsal and lateral trajectories (arrows in Fig. 2j ). This local dynamic displacement of ENF-to-EPF cytological structures was completed within 24 hours.
We then analysed the migration behaviours of single cells in 3D by automatically tracking the migration paths of EPFs at 15-min intervals. We obtained 144 high-quality tracks of fibroblasts across an area of ~170 µ m 2 and ~100-µ m deep (Fig. 3a) . From a coronal plane of view, we observed characteristic reticular patterns in which EPFs follow seemingly collective behaviours (Fig. 3b) . The EPFs migrated in vertical columns along the dorsal-ventral axis (Fig. 3c,d ). Anterior tracks had more dispersed points along the dorsal-ventral axis than posterior tracks, indicating that anterior EPFs migrated faster than posterior EPFs (Fig. 3e,f) .
Unexpectedly, EPFs migrated ununiformly and in three distinctive ways: (1) 'converging' migration to a fixed space (Fig. 3b) , (2) 'localized' migration where EPFs move in a limited space without directly contacting each other (Fig. 3g) or (3) 'diverging' migration of several EPFs from a space unit (Fig. 3h) . These three migration types occurred in clusters of 3-6 fibroblasts that shared common behaviours. Sequences of several units with varied migration behaviours could be detected even along a relative short distance of 170 µ m, indicating that EPF movements in situ are directed locally by microenvironmental cues. These observations are in contrast to observations from fibroblast migration assays in 2D and demonstrate that EPFs exhibit intricate migration repertoires in vivo.
Dermal lattice development follows En1 lineage replacement.
Having documented the cellular conversion from ENFs to EPFs, we went on to describe dermal lattice development. As the dermal structure is too complex to be analysed with simple Euclidean geometry parameters, we turned to fractal analysis to measure the complexity of cellular and ECM fibre arrangements. In this analysis, the fractal dimensions (FD) and lacunarity (L) values quantitatively assess the complexity and porosity of 2D shapes ( Supplementary Fig. 5a ). The complex arrangements (for example, blood vessels and tumours [20] [21] [22] ) score higher FD values than simpler arrangements (for example, geometrical shapes). Porous structures (for example, sponges) score higher L values than smooth surfaces (for example, scales).
We first resolved the cellular organization during dermal morphogenesis using histological sections of En1 Cre ;R26 VT2/GK3 embryos. Early (E11.5-E12.5) ENF regions were smoother and more complex, whereas later stages (E14.5-E16.5) became simpler and more porous ( Supplementary Fig. 5b,c ). This indicates a drift from a compact mesenchymal arrangement to a more interspaced cellular organization of a mature dermis. Anterior ENF arrangements at E12.5 were more complex and smoother than posterior cells ( Supplementary Fig. 5c ), indicating that, at E12.5, anterior and posterior regions have different cellular organizations.
Conversely, EPFs underwent two major cellular rearrangements during development: (1) early EPFs (E10.5-E11.5) cluster tightly in complex patterns, with individual cells having smooth shapes; and (2) after E12.5, these clusters split into individual cells with increasing complex arrangements (Fig. 4a,b) . At E12.5, anterior EPFs decreased in FD value, whereas posterior EPFs retained similar complexity to their earlier stage. 3D-rendered pictures of single EPFs revealed that posterior EPFs were morphologically simpler than anterior EPFs (Fig. 4c) . A sudden increase in complexity of anterior EPFs in E12.5 embryos correlated in time with the migration of EPFs (Figs. 2f,j and 3, Supplementary Fig. 4 and Supplementary Videos 1 and 2), suggesting that changes in EPF morphology cause or are caused by migrations. Together, our fractal analysis characterizes dynamic spatiotemporal changes in dermal lattice development and link dermal maturation steps to distinct embryonic fibroblastic lineages.
To determine whether dermal lattice organization is changed following the expansion of EPFs, we analysed matrix fibre alignment at different stages in dermal regions that do or do not contain EPFs. As collagen precludes the earlier stages of development where EPFs initially seed the back-skin, we used fibronectin to study the patterns of dermal lattice development. The distance between fibres increased progressively from E11.5 to E16.5 ( Fig. 4d and Supplementary  Fig. 6 ), concurrent with EPF development. At the same time, there was a progressive decrease in complexity and an increase in porosity ( Fig. 4e,f) . This demonstrates that a gradual transformation of the dermal fibronectin matrix occurs, from a relaxed and disorganized framework towards a more stretched conformation (Fig. 4g) . Our fractal analysis of EPF's cellular arrangements stresses that E12.5 is a pivotal time-point when anterior regions are actively changing while posterior regions are still dormant. The co-occurrence of fibronectin framework transformation and EPF morphological changes links ECM arrangements with distinct cell-migration behaviours during development. To directly prove this link, we used an inducible-Cre labelling system to follow single fibroblastic cells (either ENFs or EPFs) and their sibling cells during back-skin development, and compared behaviours between anterior and posterior sites. Fibroblastic clone size increased and clone expansion extended across the dorsal-ventral axis in the most anterior locations, whereas singly labelled cells and small clones remained close to the ectoderm in posterior regions (Fig. 4h,i) . These experiments show that the dynamics of structural changes across the anterior-posterior dermal axis influence both the cell division rate of fibroblastic precursors and the migration trajectories of their clonal colonies.
Next, we aimed to detect in more detail discrete cellular arrangements at later stages, when fibroblast clones are too widespread and intermixed. We generated a tissue-level description of dermal cellular organization by calculating local FD and L values from E16.5 En1
Cre ;R26 VT2/GK3 embryos. Low-power images showed that morecompact tissues, such as the epidermis, hypodermis, muscle and cartilage, had higher FD values than the dermis ( Supplementary  Fig. 5d,e) , indicating the validity of the fractal analysis. From the high-power images, we could identify five distinct dermal layers (DL-1-DL-5) organized in parallel sheets across the back-skin (Fig. 4j-n) . DL-1 and DL-5 were in direct contact with the epidermis and the hypodermis, respectively, were more complex and smoother, and were composed of densely packed EPFs (~85% and ~75%, respectively). DL-2 and DL-4 were simpler and porous, and were composed predominantly of EPFs (~75% and ~90%, respectively). DL-3 was complex and porous and was composed primarily of elongated ENFs (~75%). Thus, the cellular organization of the dermis at E16.5 has a mirrored pattern with outer flanking dense dermal layers that are in direct contact with the epidermis and the hypodermis, and two intermediate porous layers, which are separated by a middle layer devoid of EPFs. Critically, within each internal layer there are microdomains with distinct complexity values across the anterior-posterior axes. Tissue structure complexity and porosity does not vary linearly across these microdomains. In fact, in several places, the deep dermis is abruptly interspersed with distinct cellular arrangements (right panels in Fig. 4j ), which might result from local migration patterns at earlier stages of development.
Scarring transition follows an anterior-to-posterior sequence.
We showed above that EPFs increase within the back-skin from an anterior-to-posterior sequence. We previously showed that adult EPFs produce scars 11 . Thus, we speculated that the fetal regeneration-to-scar transition is linked to engrailed lineage replacement and could be due to the gradual increase in EPF abundance during dermal development. If this is correct, we would expect that wounds inflicted at early fetal stages would regenerate from ENFs and that the transition from regeneration-to-scarring would take on an anterior-to-posterior sequence.
To test our first hypothesis, we generated wounds in the backskin of En1 Cre ;R26 mTmG E12.5 embryos and analysed both lineage compositions and ECM depositions (Fig. 5a) . At 48 hours postwounding, ENFs had migrated into wound beds, where a provisional fibronectin-rich matrix had been generated, virtually absent of EPFs or collagen I fibres (Fig. 5b,c) . Fractal analysis of fetal wounds indicated that lattice arrangement at the injury site was not different from that of the adjacent fetal skin (Fig. 5d-f) . Thus, during fetal skin regeneration, ENFs sculpt the wound-bed matrix without the intervention of EPFs.
To test our second hypothesis, we cultured skin biopsies from different anterior-posterior regions of E19.5 wild-type (WT) embryos (Fig. 5g) . Anterior biopsies deposited significantly more collagenrich scars (right panel in Fig. 5h ) than posterior biopsies (left panel in Fig. 5h ). Fractal analysis revealed that the posterior matrix was significantly simpler than the anterior matrix (Fig. 5i) , suggesting that, at this stage, anterior fibroblasts are more fitted to create a scar than are posterior fibroblasts. Collectively, these experiments demonstrate that the fetal regeneration-to-scar transition follows the increase in EPF abundance during dermal development.
En1 lineage replacement drives regeneration-to-scar transition. We next asked whether EPFs from early stages possess scarring capacities or whether, alternatively, they undergo a developmental maturation, whereby they acquire scar-producing abilities over time. To test this idea, we purified EPFs from the back-skin of En1
Cre ;R26 mTmG embryos/ neonates at regenerating (E16.5) or scarring (P1) stages and intradermally transplanted them in equal number (2 × 10 5 ) around the edges of fresh splinted wounds on the back-skin of adult immunodeficient (Rag2 -/-) mice. We then assessed the contribution of EPFs from different ages to scar formation 14 days after transplantation/wounding (Fig. 6a) . Transplanted EPFs from P1 that migrated into the wounds deposited collagen I extensively within host wound beds (Fig. 6b) . Some EPFs deposited ectopic collagen I at their original transplanted location (Fig. 6c) . Strikingly, transplanted EPFs from E16.5 embryos had the same scarring capacities as P1 EPFs, depositing collagen I both within wounds and at ectopic uninjured sites (Fig. 6d,e) . EPFs from both E16.5 and P1 had pathologically active cell morphologies, with membrane protrusions that span across and intermingle with the collagen I fibres (Fig. 6e) . Fractal analysis showed that collagen I arrangements were more complex and smoother in EPF-transplanted regions (day 14 post-wounding) and in adult scars (day 21 postwounding) than in non-injured adult and fetal dermis, which were simpler and more porous (Fig. 6f ). Our results demonstrate that fetal EPFs are capable of producing and organizing a scar tissue, just as well as newborn EPFs, and that the absence of scar formation in early fetal skin is due to scarcity of EPFs, rather than their developmental immaturity. Together, the mechanism behind the dynamic transition from regeneration to scarring in fetus is En1 lineage replacement during back-skin development.
ENFs or native lattice reduce scarring in adult wounds. As we found that ENF abundance in the dermis was associated with regenerative outcomes at early stages and as we also showed that ENFs sculpted a provisional lattice during development, we asked whether transplantation of ENFs alone would regenerate adult dermal wounds. To test this hypothesis, we transplanted fetal (E16.5) ENFs into back-skin wounds of adult Rag2 -/-mice and allowed wounds to heal for 14 days (Fig. 7a) . As expected, sites of ENF transplantations had a more reticular lattice arrangement than fibrotic lattice arrangements at sites of EPF transplantations (Fig. 7b,c) . Fractal analysis indicated that ENF transplantation sites were significantly simpler and more porous in lattice arrangements than EPF-transplanted sites or mock-transplanted control wounds (Fig. 7d) . In line with the reduction of scarring severity, immunolabelling of an endothelial marker, CD31, showed a significantly higher infiltration of blood vessels into the wound beds at sites of ENF transplantations than EPF-transplanted or mock-transplanted wounds (Fig. 7e-i) . Many of the transplanted ENFs were closely associated with blood vessels, which were interlaced with one another to generate vascular networks within the transplanted sites (Fig. 7g) .
To test whether the ENF-generated lattice itself promotes a regenerative outcome, we transplanted decellularized back-skin from P5 WT mice into back-skin wounds of Rag2 -/-mice (Fig. 7j) . Ten days later, we found that fibroblasts in the control wounds and in the borders between the wound and the transplanted matrix had a typical active morphology with membrane protrusions (Fig. 7k,l) . Conversely, resident cells within the transplanted matrix had an inactive morphology with round cytoplasm (Fig. 7m) . Immunolabelling of α -SMA revealed that the activated fibroblasts were present in the control wound beds and in the matrix-wound border (Fig. 7n,o) and were mostly devoid from transplanted matrix (Fig. 7p) . These experiments show that a 'healthy' dermal lattice can be imposed locally in two ways. First, transplanting ENFs expands the existing pool of resident ENFs and allows ENFs to sculpt a provisional matrix. Alternatively, transplantations of decellularized dermal lattice, in essence, mimic dermal development, and in the presence of which EPFs do not promote a pathological scar. Both approaches, if they could be made industrially, provide therapeutic possibilities for a range of dermal pathologies, including patients with large skin burns or wounds.
Discussion
We have previously shown 11 that EPFs are the primary cells responsible for fibrotic outcomes in adult settings of wound healing, irradiation fibrosis and melanoma cancer growth. Here, we find that ENFs, not EPFs, are the primary sculptors that drive dermal lattice development and its regeneration in fetal wound-healing settings. We show that transplanted fetal ENFs and EPFs into adult wounds impose regenerative versus scarring outcomes, respectively, and that the phenotypic shift in dermal response to injury (from regeneration to scarring) is driven by En1 lineage replacement ( Supplementary Fig. 7 ).
Using in vivo live imaging, we disclose three distinct migration patterns of dermal fibroblasts during back-skin development: localized, diverging or converging migrations. To our knowledge, these migration patterns have never been described in 2D or 3D assays to date. We hypothesize that each of the three migration patterns establishes distinct dermal architectures that collectively drive the remarkable architectural complexity that we observe during dermal development. Diverging migration patterns could indicate fibroblastic cell invasiveness, whereas converging migrations indicate collective and interconnected behaviours as opposed to individualistic. As fibroblastic migrations impinge on collagen-bundle alignments, we expect these individual migration patterns, through their distinct molecular programmes, to influence scar tissue severity, as well as fibroblastic invasiveness into tumours.
Our findings have additional developmental, evolutionary and clinical implications outlined below.
Other groups have recently implicated separate fibroblastic lineages in the differentiation of the back-skin epidermis 18, 23, 24 . Fetal processes of epidermal development, hair follicle and sebaceous gland differentiation may require specialized stromal signals and cells. The priority for adults is a quick fix of breached skin, which probably requires different stromal signals and cells to produce a scar. These two diverged requirements at different stages of fetal life are maintained through dynamic cellular shuffling of fibroblastic populations, allowing specialized types of fibroblasts to accommodate specific fetal and adult requirements.
We demonstrate here that the ENF-to-EPF switch in the dermis imposes the phenotypic transition from regeneration to scarring in response to injury. In evolutionary terms, this switch provides a model to explain how dermal regeneration was retained in some adult rodent species such as African spiny mice 25 . We speculate that such species have retained the fibroblastic cell compositions of fetalstage dermis (ENFs > EPFs), and have resisted the ENF-to-EPF lineage successions.
Here, we describe, and map in detail, a mechanism for the general acquisition of scarring ability in the skin. We believe both the temporal and the spatial dynamics of EPFs, the determinants of scarring, will be widely clinically applicable. Consideration of lineages with engrailed history will outline a favourable time window for surgeons to work in, when scarring outcomes will be predicted to be at a bare minimum, such as during corrective surgery for spina bifida, or equally, it could be applicable to the removal of paediatric malignancies.
Our findings also carry implications for adult scarring. There are no definitive strategies to prevent scar formation, and current clinical practice is focused on scar acceptance rather than its amelioration. We have demonstrated two separate strategies that reduce scar outcomes in adult injured skin. Both ENF transplantation and decellularized dermis transplantation assays provide a proof of concept for a therapeutic option that could be used to treat large wounds, scolds or burns.
Our findings also create opportunities for the intense field of bioengineered autologous dermoepidermal human skin grafts that are currently being tested in phase I and phase II clinical studies. Skin grafts include all fibroblastic lineages within the dermis and are therefore likely to produce scars upon transplantation. We predict it would be advantageous to graft pure human ENFs or ENFs combined with dermoepidermal skin. In essence, this dermal milieu would override the ENF-to-EPF population shift and favour regeneration over scarring.
In summary, we used single-cell clonal analysis, 3D imaging, computational cell tracking and in silico analysis to follow the behaviours of fibroblast lineages in vivo. We document fibroblastlineage-specific proliferations, migrations and secretions, and demonstrate how such a fundamental process as dermal morphogenesis actually occurs. Our finding of En1 lineage replacement links dermal morphogenesis with the phenotypic shift in response to dermal injury. We believe our findings open up previously unrecognized opportunities for clinical approaches to ameliorate scar tissues in injured adult skin.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41556-018-0073-8.
Mice strains and genotyping. All mouse strains (C57BL/6J (WT), En1
Cre ,
Actin
Cre-ER , R26
VT2/GK3
, R26 mTmG and Rag2 -/-) were either obtained from Jackson laboratories, Charles River, or generated at the Stanford University Research Animal Facility as described previously 11 , and were housed at the Helmholtz Center Animal Facility. The rooms were maintained at constant temperature and humidity with a 12-h light cycle. Animals were allowed food and water ad libitum. ). The genomic DNA from the ear clips was extracted using QuickExtract DNA extraction solution (Epicenter) following the manufacturer's guidelines. DNA extract (1 µ l) was added to each 24 µ l PCR. The reaction mixture was set up using Taq PCR core kit (Qiagen) containing 1× coral buffer, 10 mM dNTPs, 0.625 units Taq polymerase, 0.5 µ M forward primer "Cre_genotype_4F"-5′ ATT GCT GTC ACT TGG TCG TGG C-3′ " (Sigma) and 0.5 µ M reverse primer "Cre_genotype_4R"-5′ GGA AAA TGC TTC TGT CCG TTT GC-3′ (Sigma). PCRs were performed with initial denaturation for 10 min at 94 °C, amplification for 30 cycles (denaturation for 30 s at 94 °C, hybridization for 30 s at 56 °C, and elongation for 30 s at 72 °C) and final elongation for 8 min at 72 °C, and then cooled to 4 °C. In every experiment, negative controls (non-template and extraction) and positive controls were included. The reactions were carried out in an Eppendorf master cycler. Reactions were analysed by gel electrophoresis.
Cell harvesting and sorting. Dorsal skin of En1
Cre ;R26 mTmG embryos, neonates or adult mice were harvested and washed with Hank's balanced salt solution (HBSS). Skin was minced into small pieces with surgical scissors and washed again with HBSS. The cells was resuspended in 2 ml of digestion solution containing 1 mg ml -1 of collagenase I, 0.5 mg ml -1 of hyaluronidase and 25 U ml -1 of DNase I, and incubated in a 37 °C water bath for 30 min with agitation. DMEM (10 ml) containing 10% FBS was added to stop the enzymatic reaction, and the suspension was filtered through a 100-µ m and then 40-µ m cell strainer. After centrifugation at 300g for 5 min, the cell pellet was resuspended in 1 ml of FACS buffer (0.5% Splinted wounds on adult mice. Splinting rings were prepared from a 0.5-mm silicone sheet (CWS-S-0.5, Grace Bio-Labs) by cutting rings with an outer diameter of 12 mm and an inner diameter of 6 mm. After washing with detergent and rinsing with water, the splints were sterilized with 70% ethanol for 30 min and air dried in a cell culture hood and kept in a sterile bottle.
Mice were anaesthetized with 100 µ l MMF (medetomidine, midazolam and fentanyl). Dorsal hair was removed by a hair clipper (Aesculap Schermaschine Exacta), followed by hair removal cream for 3-5 min. Two full-thickness excisional wounds were created with a 5-mm diameter biopsy punch (Stiefel). One side of a splint was applied with silicone elastomer super glue (Kwik-Sil Adhesive, World Precision Instruments) and placed around the wound. The splint was secured with 5 sutures of 6.0 nylon, and the wound was covered with Tegaderm transparent dressing (3 M). Mice were recovered from anaesthesia with an MMF antagonist and were supplied with metamizol (500 mg metamizol/ 250 ml drinking water) as postoperative analgesia.
Cell transplants. Sorted cells were washed with PBS and resuspended in PBS at 4 × 10 6 cells per ml and mixed with an equal volume of ice-cold Matrigel (growth factor reduced, phenol red free) (356231, Corning) to obtain EPF and ENF suspensions in Matrigel at a final concentration of 2 × 10 6 cells per ml, and stored on ice until injection for transplantation. The Rag2 -/-mice at 10-12 weeks of age were used as recipients of transplanted EPFs and ENFs. Two 5-mm diameter full-thickness excisional wounds were created on the back-skin of SCID mice as described above. Then, two injections of 50 µ l of prepared EPF-Matrigel or ENF-Matrigel solution at a concentration of 2 × 10 6 cells per ml were made intradermally around each wound, which resulted in intradermal transplantation of 2 × 10 5 EPFs or ENFs to each wound. Control wounds received two intradermal injections of 50 µ l PBS. Fifteen minutes after injection, the silicone splints were applied and fixed around the wounds as described above. Scar tissues were harvested 14 days post-wounding and fixed with 2% paraformaldehyde at 4 °C overnight. After washing three times with PBS, the tissues were processed for histology as described below.
Transplantation of decellularized skin. The dorsal skin of C57BL/6J mice (age P5) were subjected to decellularization as described previously 26 . Briefly, the skin tissue was incubated sequentially with: (1) distilled water containing 0.1% Triton X-100 and 5× penicillin/streptomycin at 4 °C for 24 h with stirring, then (2) distilled water containing 2% sodium deoxycholate at 4 °C for 24 h with stirring, (3) distilled water containing 1 M NaCl, 5× penicillin/streptomycin at room temperature for 1 h, and finally, (4) distilled water containing 30 µ g ml -1 porcine pancreatic DNase, 1.3 mM MgSO 4 , 2 mM CaCl 2 and 5× penicillin/streptomycin at room temperature for 1 h. The decellularized skin was stored in PBS at 4 °C until transplantation. Two 5-mm diameter full-thickness excisional wounds were created on the dorsal back of each recipient Rag2 -/-mouse. A 5-mm diameter biopsy of decellularized donor skin was transplanted to the recipient's wound with silicone elastomer super glue (Kwik-Sil Adhesive, World Precision Instruments). Wounds without a transplant served as control. Subsequently, the wounds were covered with a 12-mm diameter silicone sheet (Grace Bio-Labs), fixed with 5 sutures, and transparent dressing was applied (3 M Tegaderm Film). The scar tissues were harvested 10 days post-wounding and processed for histology.
Ex vivo wounding. E12.5 embryos were harvested from En1
Cre ;R26 mTmG breeding. Cre + embryos were selected based on GFP positivity by observing them under a fluorescence stereomicroscope (Leica M205 FA). Small excisional wounds were created on the dorsal back of embryos by using fine microsurgical scissors (Vannas Spring Scissors, Fine Science Tools) under the stereomicroscope (Leica M50). The embryos were kept in Knockout DMEM (Thermo Fisher) supplemented with 10% KnockOut Serum Replacement (Thermo Fisher), 1% penicillin/streptavidin (Thermo Fisher), 1% GlutaMAX (Thermo Fisher) and 1% Non-Essential Amino Acids solution (Thermo Fisher) in a 37 °C, 5% CO 2 incubator. Embryos were fixed with 2% paraformaldehyde at 12 h, 24 h and 48 h after culture and processed for histology.
Ex vivo tamoxifen treatment. E12.5 embryos were harvested from Actin
Cre-ER
;R26
VT2/GK3 breeding. The embryos were kept in Knockout DMEM supplemented with 10% KnockOut Serum Replacement, 1% penicillin/ streptavidin, 1% GlutaMAX, 1% Non-Essential Amino Acids solution and 1 nM 4-hydroxytamoxifen (Sigma-Aldrich) in a 37 °C, 5% CO 2 incubator. Twenty-four hours later, embryos were fixed overnight with 2% paraformaldehyde at 4 °C and processed for histology.
Histology. Tissue samples were fixed overnight with 2% paraformaldehyde in PBS at 4 °C. Samples were rinsed three times with PBS, embedded in optimal cutting temperature (OCT) compound (Sakura Finetek) and flash-frozen on dry ice. Six μ m sections were made in a Hyrax C50 Zeiss Cryostat.
Masson's trichrome staining was performed with a Sigma-Aldrich Trichrome stain kit, according to the manufacturer's instructions.
For immunostainings, sections were air dried for 5 min followed by fixation with − 20 °C-chilled Acetone for 20 min. Sections were rinsed three times with PBS and blocked for 1 h at room temperature in PBS plus 5% serum. Then, the sections were incubated with the primary antibody in PBS serum overnight at 4 °C or for 90 min at room temperature. Sections were then rinsed three times with PBS and incubated with the secondary antibody in PBS serum for 60 min at room temperature. Finally, sections were rinsed three times in PBS and mounted with fluorescent mounting media with 4,6-diamidino-2-phenylindole (DAPI).
TUNEL (Life technologies) staining was performed prior to immunolabelling according to the manufacturer's recommendations but avoiding proteinase K treatment. Live imaging. Pregnant mice were killed 12.5 d.p.c. (days post-coitum) by cervical dislocation and uteri were excised. Embryos were dissected in ice-cold medium and tested for Cre + fluorescence. Excised Cre + embryos were incubated with SiR-DNA (Spirochrome) for 1 h (at 37° with 5% CO 2 ). The embryos were embedded in 35-mm glass bottom dishes (Ibidi) and Matrigel (Corning) and the gel was allowed to solidify for 30 min. Imaging medium (DMEM/F-12; SiR-DNA 1:1,000) was then added. Twenty-four-hour time-lapse imaging was performed using a Zeiss LSM 710, equipped with 488-nm, 515-nm and 633-nm laser lines and a × 20 objective. Temperature control was set to 37 °C with 5% CO 2 -supplemented air. Three channels (GFP, tdTomato and AF647) were recorded every 15 min as a z-stack of 188-µ m thickness. The 4D data were processed with Imaris 9.1.0 (Bitplane) and ImageJ. Contrast and brightness were adjusted for better visibility.
Cell tracking. 3D drift correction was applied on the live-imaging 4D data using the ImageJ's Correct 3D Drift' in reference to the EPF channel. The resultant driftcorrected data sets were subjected to maximum intensity projection and visualized to verify compensation of the apparent drift in reference to the imaging plane. The corrected data sets were subjected to cell migration and cell-tracking analysis using 'Trackmate' . Variables, such as blob diameter, threshold, detector (Laplacian of Gaussian (LoG) segmentation) and the LAP (linear assignment problem) tracker, were adjusted to suit the nature of the data and the samples as described in the plugin workflow 27 . Filters, such as spots with good quality, mean intensity and uniform colour, were applied and tracked using the LAP Tracker. Individual track information and the coordinates of these data points were exported as an Excel file. Graphical representation and visualization of 4D data sets were performed using a R script in the 'scatterplot3D' package to represent the tracks on a 3D plane. For the fourth dimension of the tracks, colour ramp was applied to the individual tracks as a function of time (blue, first time point; red, last time point of the track). To visualize the data points on a 3D interactive space (360° rotation and zoom function), the R package 'rgl: 3D visualization using openGL' was integrated into the script.
3D imaging. Samples were fixed in 2% paraformaldehyde at 4 °C overnight and imaged in a 35-mm glass-bottom dish (Ibidi).
Cleared samples were processed using a modified 3Disco protocol. In short, samples were stained with anti-GFP (Abcam) and anti-RFP (SICGEN) for 4 days, followed by incubation with AF488 and AF647 secondary antibodies (Molecular Probes) for 2 days. Clearing was performed after dehydration in an ascending tetrahydrofuran (Sigma) series, with 30-min incubation in dichloromethane (Sigma) and eventually with immersion in dibenzyl ether (Sigma). Imaging was performed in dibenzyl ether with an inverted confocal (LSM 710, Zeiss) using a × 10 or × 20 objectives. Stacks were recorded in the green and far-red channels. 3D visualization and recording of movies were performed using Imaris 9.1.0 (Bitplane).
Image analysis. Single × 10 or × 63 images were taken of the EPF-containing anterior and posterior fields, in the same section, using a confocal LSM 710 (Zeiss).
Image processing and analysis were performed with ImageJ (ImageJ 1.47 (ref. 28 )). For separating EPF and ENF fluorescent signals, only the red population of EPFs was analysed from sections from 'Rainbow' mouse, as it provided the strongest signal. Channels from the raw images were split, the background was subtracted (rolling ball radius = 50 pixels) and contrast was enhanced (pixel saturation = 0.1, normalized). The 'unsharp mask' and 'median' filters were applied (radius = 10, mask = 0.60; and radius = 1, respectively). The auto-threshold method 'Yen' was used to make binary images except for the immunostaining signal of fibronectin and collagen I, for which 'default' method was used. To avoid the inclusion of background signal into the analysis, the pixels from the ENF signal were subtracted from the EPF signal and vice versa using the image calculator function. For segmentation of the blue colour from trichrome stains, × 10 bright-field images were taken with a vertical Axio scope (Zeiss). Images were transformed into CMYK and only the cyan channel was used for further separation, the background was subtracted (rolling ball radius = 20 pixels) and contrast was enhanced (pixel saturation = 0.1, normalized). The 'unsharp mask' and 'median' filters were applied (radius = 2, mask = 0.60; and radius = 1, respectively). The auto-threshold method 'Moments' was used to make binary images, and the 'despeckle' function was used to avoid the inclusion of the background signal into the analysis.
Fractal analysis was performed using the ImageJ plug in 'FracLac' 29 (FracLac 2015Sep090313a9390) . FD values were calculated using the box counting scan (20 slipping and tighten grids at default sampling sizes, minimum pixel density threshold = 0.40). L values was calculated using the sliding box scan (slipping and tighten grid at default sampling sizes, minimum pixel density threshold = 0.40). Local FD and L values were calculated using the subsample scan (1 grid at default sampling size, minimum pixel density threshold = 0.40, subscan in rectangles). Individual values within the discernible distinct dermal layers were manually pooled.
For the collagen I intensity analysis, sections of En1
Cre ;R26 VT2/GK3 embryos at different stages were immunostained for collagen I. × 63 images were segmented as before. Segmented EPF and ENF binary images were further processed (Options: Process_Binary_Fill Holes, and Process_Binary_Close) and a region of interest selection was created to measure the mean grey values from the raw images. The mean grey values from the region of interest were normalized with the general mean grey values of the image. Three images from every condition were analysed.
For the fibronectin fibre distance measurements, sections of En1
embryos at different stages were immunostained for fibronectin. × 63 images were segmented as before. We used the plot profile function in diagonal lines of fibronectin segmented images, and the distance between the fibres was calculated as the gaps between the signal peaks. Three images from every condition were analysed.
Statistics and reproducibility. Statistical analyses were performed using GraphPad Prism software (version 6.0, GraphPad). Statistical significance was determined using Student's t-test or analysis of variance (ANOVA) with Tukey, Holm-Sidak or Newman-Keuls multiple comparison test, as indicated in the corresponding figure legends. All experiments presented in the manuscript were repeated in at least three independent experiments/biological replicates with similar results, unless indicated otherwise in the figure legend. Cell-tracking data shown in Fig. 3 were derived from 144 high-quality tracks of one representative video. Fig. 7 was derived from two independent transplantation experiments of mock control, EPFs, ENFs and decellularized skin. No statistical method to predetermine sample size was used.
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